Recognition and function analysis of MKK6 in immune reaction against Vibrio Parahaemolyticus in Crassostrea hongkongensis
PLOS One · 2026
DOI: 10.1371/journal.pone.0360613 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Jiexiong Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fishery College of Guangdong Ocean University, Zhanjiang, China. Hauptthemen laut MEDLINE: Vibrio parahaemolyticus, Crassostrea, MAP Kinase Kinase 6. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, National key research and development program of China, Postgraduate Education Innovation Project of Guangdong Ocean University.
Abstract (Originalsprache)
MKK6 is a key protein kinase that regulates inflammatory response under pathogen infection by activating MAPK signal pathway. However, the function of MKK6 remained unclear within oysters. Our research recognized a novel KK6 gene from C. hongkongensis , which is named ChMKK6 . The cDNA of ChMKK6 gene was 2,760 bp in length, containing an ORF of 1,032 bp encoding 344 amino acids, with a conserved S-TKc region and a DVD region. As illustrated by amino acid alignment and phylogenetic tree, ChMKK6 shared the maximal (99.0%) identity showing MKK6 of Crassostrea gigas. As indicated by tissue expression analysis, ChMKK6 possessed the maximal expression within hepatopancreas, and was markedly increased in all tissues following Vibrio Parahaemolyticus ( V. Parahaemolyticus ) challenge. As stated by the qRT-PCR analysis, ChMKK6 silencing significantly suppressed IL17 transcription, suggesting its involvement in innate immunity by regulating IL17 -mediated inflammatory response. Moreover, ChMKK6 silencing led to the suppression of key immune-related enzyme activities (ACP, AKP, CAT, LZM, and SOD), while raising the MDA content in gill. In addition, the antimicrobial viability of hemolymph supernatant was markedly reduced by ChMKK6 silencing. These results collectively demonstrate that ChMKK6 is a key player in immunity defense of C. hongkongensis from V. Parahaemolyticus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fishery College of Guangdong Ocean University, Zhanjiang, China.
- Academician Joint Laboratory of Germplasm Resource Exploitation, Utilization and Health Assessment for Aquatic Animal, Guangdong Ocean University, Zhanjiang, China.
- Guangdong Provincial Key Laboratory of Aquatic Animal Disease Control and Healthy Culture, College of Fisheries, Guangdong Ocean University, Zhanjiang, China.
- FangchenggangVocational and Technical College, Fangchenggang, China.
ORCID-Profile: Feifei Yu
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- National key research and development program of China
- Postgraduate Education Innovation Project of Guangdong Ocean University
- the Projects of Innovation Team of Colleges and Universities in Guangdong Province
- 2025 basic ability improvement project for young and middle-aged teachers in colleges and universities in Guangxi
Zitieren
APA
Zhu, J., Shao, G., Chen, J., Lin, J., Liang, Q., Yu, F., Wang, Z., Lin, B., Huang, Y., Li, H., & Xu, J. (2026). Recognition and function analysis of MKK6 in immune reaction against Vibrio Parahaemolyticus in Crassostrea hongkongensis. PLOS One. https://doi.org/10.1371/journal.pone.0360613
Vancouver
Zhu J, Shao G, Chen J, Lin J, Liang Q, Yu F, et al. Recognition and function analysis of MKK6 in immune reaction against Vibrio Parahaemolyticus in Crassostrea hongkongensis. PLOS One. 2026. doi:10.1371/journal.pone.0360613
BibTeX
@article{Zhu2026,
author = {Zhu, Jiexiong and Shao, Guohui and Chen, Jiayu and Lin, Jinji and Liang, Qiwen and Yu, Feifei and Wang, Zhiwen and Lin, Baixu and Huang, Yongyao and Li, Huiyan and Xu, Junhui},
title = {Recognition and function analysis of MKK6 in immune reaction against Vibrio Parahaemolyticus in Crassostrea hongkongensis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0360613}
}
EUVIMED